About HER2/ERBB2

The ERBB2 gene (also known as HER2, human epidermal growth factor receptor 2) on chromosome 17q12 encodes a receptor tyrosine kinase in the EGFR family. HER2 amplification and overexpression occur in ~20% of breast cancers and are key biomarkers for targeted therapy. ERBB2 spans ~40 kb with 27 coding exons.

NCBI Gene ID: 2064 | RefSeq: NM_004448.3 | Genomic: NC_000017.11 (39688492-39728990)

HER2/ERBB2 Primer Design Challenges

  • Amplification quantification: qPCR requires reference gene co-amplification (e.g., RNaseP or TOP2A) for copy number normalization
  • GC-rich regions: Exons 1–5 contain 60–70% GC content requiring optimized parameters
  • Gene duplication: ERBB2 amplification in tumors requires primers that avoid homologous ERBB family members (EGFR, ERBB3, ERBB4)
  • Alternative transcripts: Multiple splice variants (including a constitutively active truncated form) require careful transcript selection
  • Clinical cut-offs: IHC/FISH correlation requires precise amplicon design for copy number assays

Recommended Primer Design Parameters for HER2/ERBB2

ParameterStandard ExonsGC-Rich Exons (1–5)
Primer length20-22 nt22-25 nt
GC content45-55%50-60%
Tm58-62°C60-65°C
Amplicon size150-300 bp180-350 bp
Annealing temp58-60°C62-65°C
PCR additiveStandardAdd 5% DMSO or 1M betaine

Key SNPs to Avoid in Primer Binding Sites

When designing HER2/ERBB2 primers, avoid these significant variants:

  • rs1136201 (p.Ile655Val) — Common polymorphism in transmembrane domain, associated with cancer risk
  • rs1058808 (p.Pro1170Ala) — C-terminal variant in exon 27
  • rs4252633 (p.Trp452Cys) — Extracellular domain missense variant

Clinical Validation Required
All HER2/ERBB2 primers designed with VigyanLLM are for research use only. Clinical diagnostic applications require additional wet-lab validation, Sanger sequencing confirmation, and regulatory approval before patient use.

Recommended Primer Sequences for HER2/ERBB2 — Engine-Designed on NM_004448.3

The three pairs below were produced by VigyanLLM's automatic primer design engine directly against the Homo sapiens HER2/ERBB2 RefSeq mRNA NM_004448.3 (4664 nt), under the engine's default constraints: 18–25 nt primers, Tm 57–72 °C (optimum 62 °C), GC 40–60%, and an 80–1500 bp amplicon (optimum 150 bp). Every oligo was then re-checked back against the accession — each forward primer matches the sense strand at its stated 1-based position and each reverse primer matches the reverse complement ending at the amplicon's final base (3 of 3 exact matches for this page).

PairForward (5′→3′)Reverse (5′→3′)Tm fwd / revGC fwd / revAmplicon
15′-ACCTTCCTTCCTGCTTGAG-3′5′-AAGGCTTTCAGTACCCAGG-3′57.3 / 57.3 °C52.6 / 52.6%178 bp (nt 4169–4346)
25′-ATCCAGGCTTTGTACAGAGTG-3′5′-ACAAAGTGGGTGTGGAGAAG-3′58.3 / 58.3 °C47.6 / 50.0%144 bp (nt 4473–4616)
35′-AGGGAGTATGTGAATGCCAG-3′5′-ACTTCCAGATGGGCATGTAG-3′57.6 / 57.6 °C50.0 / 50.0%193 bp (nt 1915–2107)

Pair 1 leads with a forward/reverse Tm spread of 0.0 °C, no stable hairpin at 37 °C (ΔG ≥ 0.0 kcal·mol−1 on either oligo), self-dimer Tm at most -13.0 °C, no cross-dimer signal, no pair warnings, and a Primer3 pair-quality score of 100.0/100; the suggested starting annealing temperature is 52.3 °C. Pairs 2 and 3 are alternates from the same run — compare their Tm, GC and product columns above against your chemistry (dye-based or probe), then confirm every candidate in silico and on a gel before use.

Specificity: not confirmed.
The engine also launched an automated Primer-BLAST pass (Homo sapiens, RefSeq mRNA), but its report parser returned no expected-amplicon hit — an inconclusive result, not a confirmation. Before ordering, run NCBI Primer-BLAST on each final pair yourself. For genomic-DNA templates this matters even more: an mRNA-based check cannot see processed pseudogenes, repeats or pseudogene-derived off-targets.

How to read this table: these are default whole-transcript designs — they demonstrate what the engine produces under standard constraints and are not positioned over the clinically relevant variants discussed below; to land an amplicon on a specific codon or repeat, design against that region deliberately. Thermodynamics come from Primer3's nearest-neighbor engine (SantaLucia 1998). Example output only: validate each candidate experimentally (gel sizing, efficiency series, melt-curve or probe check) before relying on it.

Design Guidance for HER2/ERBB2 Assays

ERBB2 (HER2) is a receptor tyrosine kinase that dimerises without a ligand; gene amplification or protein overexpression occurs in roughly 15–20% of breast cancers and is both a prognostic marker and a therapeutic target. ERBB2 is therefore measured by several routes at once — copy number on genomic DNA, mRNA expression on cDNA, and protein by IHC — and each route needs its own primer logic.

For copy-number qPCR or ddPCR, primers must be strictly single-locus (screen repeats out of the amplicon), the product should be short (150 bp or less), and the result is only meaningful relative to a validated reference locus — RNase P is a standard single-copy reference in human DNA copy-number work. Expression assays have a different hazard: the ERBB family shares conserved regions with EGFR, ERBB3 and ERBB4, so choose primers in ERBB2-specific sequence (the 3′ UTR diverges from family members) and validate against a panel of reference genes rather than a single one. State the RefSeq (NM_004448.3 for the example pairs) and confirm specificity in silico before ordering.

Before you order: re-check both binding sites against dbSNP and gnomAD — a common variant under one primer causes allele dropout and mysterious assay failures — confirm specificity in silico for the template you will actually use, run an annealing gradient around 52.3 °C (the engine's starting suggestion for pair 1), verify a single band of the expected size on a gel, and record primer sequence, lot and efficiency with the run as MIQE requires.

References

  • NCBI Nucleotide — RefSeq NM_004448.3 (Homo sapiens HER2/ERBB2 mRNA).
  • NCBI Gene — HER2/ERBB2 (Homo sapiens).
  • SantaLucia J Jr. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc Natl Acad Sci USA 1998;95:1460–1465.
  • Untergasser A, Cutcutache I, Koressaar T, et al. Primer3—new capabilities and interfaces. Nucleic Acids Res 2012;40:W115–W118.
  • Ye J, Coulouris G, Zaretskaya I, et al. Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. Nucleic Acids Res 2009.
  • Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611–622.

Design HER2/ERBB2 Primers Now

Pre-configured with HER2-specific parameters. Enter exon number or genomic coordinates.

Design HER2/ERBB2 Primers →